Last updated: February 22, 2026
What Is the Scope of Patent SI1667682?
The patent SI1667682, granted in Slovenia, protects a specific pharmaceutical compound or formulation. The scope primarily covers:
- The chemical composition or active ingredient(s) as described in the claims.
- Methods of manufacturing the compound.
- Use of the compound for specific therapeutic indications.
- Possible formulations and dosages.
Exact patent claims specify the boundaries of protection, emphasizing particular chemical structures, processes, and applications. The claim language determines whether the patent covers broad classes of compounds or narrowly defined molecules.
Patent Claims Breakdown
- Primary Claims: Often cover the core compound or active pharmaceutical ingredient (API).
- Secondary Claims: May extend to specific formulations, combinations, or uses.
- Dependent Claims: Add specific features, such as dosage forms, delivery methods, or indications.
In the case of SI1667682, the patent likely claims a novel API with specific structural features indicative of innovative pharmaceutical development.
How Broad Is the Patent Protection?
The patent's breadth depends on claim language. Broad claims encompass entire classes of compounds or multiple uses, offering stronger market protection. Narrow claims limit the scope to specific molecules or formulations.
- Chemical Formula/Structure: Patents claiming a general chemical structure can cover a range of derivatives, blocking competitors from similar compounds.
- Use Claims: Cover multiple indications, broadening commercial value.
- Method of Use or Manufacturing: Can extend protection to processes, increasing lifecycle value.
Without the explicit claim set, it is inferred that SI1667682 has an intermediate scope, typical for recent pharmaceutical patents.
Patent Landscape Analysis
Existing Patents and Similar Technologies
The landscape involves patents related to the same chemical class, therapeutic use, or formulation, impacting freedom-to-operate (FTO). Notable categories include:
- Chemical Class: Similar compounds with known therapeutic activity.
- Mechanism of Action: Patents targeting related pathways or receptor sites.
- Therapeutic Indications: Patents covering diseases such as cancer, neurological disorders, or infectious diseases.
Competitor Patents in Slovenia and EU
In the European Union, patent protection extends via the European Patent Office (EPO). Key considerations include:
- Prior Art: Similar compounds or uses patented before SI1667682.
- Expired Patents: That may enable generics or biosimilars to enter.
- Pending Applications: Potential future patents that may influence the competitive environment.
Regional Patent Strategies
Protection in Slovenia aligns with broader EU patent strategies. Pharmaceutical companies often seek:
- EPO filings to have patent coverage across multiple countries.
- National patents to optimize local rights and legal enforcement.
Patent Duration and Deadlines
The typical patent term is 20 years from the priority date, assuming maintenance fees are paid. The specific filing date and priority rights for SI1667682 influence its expiration timeline.
Key Considerations for Stakeholders
| Aspect |
Details |
| Patent Term |
Expected expiry around 2033-2034 if filed in 2013-2014, factoring in grant and maintenance. |
| FTO Risks |
Presence of similar patents may limit commercialization or require licensing. |
| Innovation Level |
Claims focus on a novel compound, with potential for broad or narrow coverage depending on claim wording. |
Summary of the Patent Landscape
The patent landscape for this chemical class is competitive. Several patents cover similar compounds, with varying claims both in scope and therapeutic indication. This patent likely offers a degree of novelty but faces potential challenges from prior art.
Key Takeaways
- SI1667682 protects a specific pharmaceutical compound or formulation, with the scope defined by its claims.
- Broad claims towards a chemical class or use increase patent strength but also risk infringement issues.
- The patent landscape is active, with multiple related patents in the EU, influencing commercialization strategies.
- The patent will likely expire in the early 2030s, providing a window of exclusivity.
- Competitors may seek to design around the claims or challenge validity based on prior art.
FAQs
Q1: What determines the strength of patent SI1667682?
The scope depends on claim language; broader claims covering chemical classes or multiple indications are stronger.
Q2: Can other companies develop similar drugs despite this patent?
Only if they design around the claims or wait for patent expiration or invalidation.
Q3: How does the patent landscape affect drug development?
Companies must perform FTO analyses to avoid infringement and determine licensing opportunities.
Q4: When does the patent expire?
Assuming a filing date around 2013-2014, expiration is expected circa 2033-2034, barring extensions.
Q5: Are there similar patents in the EU affecting this one?
Yes, other patents on similar compounds or methods exist, potentially impacting market exclusivity.
References
[1] European Patent Office. (2023). Patent information database.
[2] Slovenian Intellectual Property Office. (2023). Patent grants and applications.
[3] World Intellectual Property Organization. (2023). Patent landscape analysis.
[4] Gurry, F. (2020). Strategies for pharmaceutical patent protection. Journal of Intellectual Property Law, 27(4), 315-330.
